Festus Ezeli Undergoes Injection in Left Knee

Portland Trail Blazers center Festus Ezeli is expected to be out six weeks after undergoing an injection in his left knee, according to the team.

Ezeli's left knee was injected with a bone marrow aspirate concentrate and Orthovisic Tuesday in Chicago. The Procedure was performed by Dr. Brian Cole and is meant to alleviate pain and improve function of the knee.

The Blazers signed Ezeli to a two-year deal worth approximately $15 million this summer, but only one year of that deal is guaranteed. Following the announcement of that deal, Marc Spears of The Undefeated reported that the cheap price tag was indeed due to concerns about the health of Ezeli's knees.

According to the American Orthopedic Foot & Ankle Society, a bone marrow aspirate is made from fluid taken from the bone marrow and it also contains stem cells that can help the healing of some bone and joint conditions.

Ezeli played only 46 games in 2015-16 and only 46 in 2014-15 as well.